Nuvalent Cl A (NUVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NUVL | CYTK | HALO | ||
| Company | Nuvalent Cl A | Cytokinetics | Halozyme Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 123.97 | 78.97 | 76.96 | ||
| High | 123.99 | 80.89 | 78.61 | ||
| Low | 123.95 | 78.82 | 76.96 | ||
| Latest | 123.96 | 80.76 | 78.49 | ||
| Change | +0.02 | +1.65 | +1.40 | ||
| % Change | +0.02% | +2.09% | +1.82% | ||
| Volume | 3,085,800 | 373,812 | 252,595 | ||
| 20-Day Average Volume | 2,194,735 | 2,205,353 | 1,847,371 | ||
| Previous Close | 123.94 | 79.11 | 77.09 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 123.61 | 83.10 | 76.78 | ||
| 20-Day Raw Stochastic | 96.00% | 19.37% | 70.37% | ||
| 20-Day Relative Strength | 64.35 | 52.35 | 59.55 | ||
| Weighted Alpha | +28.91 | +67.07 | +33.41 | ||
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 07/07/26 | -2.09% since 07/14/26 | +4.33% since 07/14/26 | ||
| Low | 123.73 on 07/08/26 | 78.27 on 07/17/26 | 73.89 on 07/15/26 | ||
| High | 123.99 on 07/14/26 | 83.71 on 07/16/26 | 79.56 on 07/17/26 | ||
| 1-Month | |||||
| %Chg | +0.58% since 06/12/26 | +1.82% since 06/18/26 | +14.22% since 06/18/26 | ||
| Low | 123.24 on 06/15/26 | 78.27 on 07/17/26 | 68.27 on 06/22/26 | ||
| High | 123.99 on 07/14/26 | 88.31 on 06/30/26 | 82.26 on 07/07/26 | ||
| 3-Month | |||||
| %Chg | +18.03% since 04/14/26 | +21.91% since 04/21/26 | +14.46% since 04/21/26 | ||
| Low | 87.30 on 06/08/26 | 58.65 on 04/29/26 | 62.38 on 05/01/26 | ||
| High | 123.99 on 07/14/26 | 88.31 on 06/30/26 | 82.26 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +14.95% since 01/14/26 | +27.24% since 01/21/26 | +9.19% since 01/21/26 | ||
| Low | 87.30 on 06/08/26 | 58.43 on 03/13/26 | 61.33 on 03/27/26 | ||
| High | 123.99 on 07/14/26 | 88.31 on 06/30/26 | 82.26 on 07/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,792,592 | 9,843,894 | 9,143,875 | ||
| Shares Outstanding, K | 78,998 | 124,433 | 118,613 | ||
| Annual Sales | 0 | 88,040,000 | 1,396,610,000 | ||
| Annual Net Income | -425,380,000 | -784,960,000 | 316,890,000 | ||
| Last Quarter Sales | 0 | 19,360,000 | 376,710,000 | ||
| Last Quarter Net Income | -109,280,000 | -206,030,000 | 150,050,000 | ||
| 60-Month Beta | 1.14 | 0.42 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.39 on 05/07/26 | -1.67 on 05/05/26 | 1.60 on 05/11/26 | ||
| Earnings Date | 08/06/26 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 18.39 | ||